Search Results - "Albalawy, Rakan"
-
1
Perivascular Adipose Tissue and Perivascular Adipose Tissue-Derived Extracellular Vesicles: New Insights in Vascular Disease
Published in Cells (Basel, Switzerland) (06-08-2024)“…Perivascular adipose tissue (PVAT) is a special deposit of fat tissue surrounding the vasculature. Previous studies suggest that PVAT modulates the vasculature…”
Get full text
Journal Article -
2
Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors
Published in Toxins (31-10-2018)“…LMB-100 is a mesothelin-targeted recombinant immunotoxin (iTox) that carries a modified exotoxin A (PE) payload. PE kills cells by inhibiting synthesis of new…”
Get full text
Journal Article -
3
Mesothelin Enhances Tumor Vascularity in Newly Forming Pancreatic Peritoneal Metastases
Published in Molecular cancer research (01-02-2020)“…Over 90% of pancreatic ductal adenocarcinomas (PDAC) express mesothelin (MSLN). Overexpression or knockdown of MSLN has been implicated in PDAC aggressiveness…”
Get full text
Journal Article -
4
Dysphagia with Blood Disorder? an Unusual Presentation for Paroxysmal Nocturnal Hemoglobinuria
Published in Blood (05-11-2020)“…Paroxysmal Nocturnal Hemoglobinuria (PNH) is an acquired hemolytic disorder of the multipotent myeloid stem cells, due to underexpression of surface complement…”
Get full text
Journal Article -
5
-
6
Abstract 3964: Mesothelin targeting immunotoxin LMB-100 alters the profile of tumor-secreted proteins
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Recombinant immunotoxins are antibody-based therapies that carry a bacterial toxin payload. LMB-100 is a next generation immunotoxin currently being tested in…”
Get full text
Journal Article -
7
Abstract 4342: Loss of MSLN impairs pancreatic cancer growth in the peritoneal cavity
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Mesothelin (MSLN) is a cell surface glycoprotein that is expressed in at least 85% of pancreatic adenocarcinoma but not on cells of the healthy pancreas nor in…”
Get full text
Journal Article